Genapsys Stock
DNA Sequencing Technology
Sign up today and learn more about Genapsys Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Genapsys Stock
GenapSys is a sequencing technology company that aims to help support the control and limit the spread of current and future outbreaks. The company's main goal is to transform research and diagnostics with an affordable, scalable genomic sequencing ecosystem.
In July 2022, Genapsys filed for Chapter 11 bankruptcy.
GenapSys was founded in 2010 and is headquartered in Redwood City, California. Notable investors include Decheng Capital, Oxford Finance Corporation, and Farallon Capital Management.Â
Investors
Oxford Finance Corporation
Foresite Capital
EverlyWell, Crossover Health, Aetion, Genapsys, Mindstrong, DNAnexus
Decheng Capital
Plug and Play
BigID, ApplyBoard, Caresyntax, Genapsys, Albert, Beyond Pricing
Funding History
March 2013 | $8.5M |
---|---|
November 2013 | $36.5M |
December 2017 | $86.2M |
February 2021 | $70.6M |
Management
Chief Executive Officer
Jason Myers
Chief Financial Officer
Britton Russell
Press
patents - Apr, 14 2024
Methods and systems for nucleic acid amplification and sequencingpatents - Apr, 14 2024
Methods and systems for nucleic acid processingglobenewswire - Jan, 26 2024
Third Generation Sequencing Market to Hit $23.92 Billion ...genomeweb - Dec, 20 2023
With Resolution Bio Acquisition, Exact Sciences Takes Aim at ...digitaljournal - Dec, 20 2023
Next-Generation Sequencing (NGS) Market Size 2023-2028 ...